Comments
Pharma major Dr. Reddy’s Laboratories Ltd has launched Valsartan tablets, a therapeutic equivalent generic version of Diovan (valsartan) tablets approved by the US Food and Drug Administration (USFDA), in the American market.
The Diovan brand and generic market had US sales of approximately $150 million for the most recent 12 months ending October 2021, according to IQVIA Health, said a company release.
Also read: After US nod, AstraZeneca moves Indian authorities over long-acting antibody mix
Dr. Reddy’s Valsartan Tablets are available in 40 mg in bottle count size of 30, and 80 mg, 160 mg, and 320 mg tablets in bottle count sizes of 90.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.